As artificial intelligence rapidly advances, how do we assess whether these systems are truly effective, ethical, and safe? Evaluation methods need to evolve beyond straightforward accuracy metrics to ...
The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback